Patrice Guerin
Latest contributions
Will the COAPT study change treatment of mitral regurgitation?
More effective, safer treatment is needed for functional mitral regurgitation (FMR), a consequence of myocardial disease and left ventricular disease, which is associated with poor quality of life and high mortality rates. Join Ralph Stephan von Bardeleben, Patrice Guerin and Saibal Kar as they examine the...
Journey toward a tailored transcatheter therapy selection part I: from mitral to tricuspid repair
22 May 2019 – From EuroPCR 2019
Find out more about how new clinical evidence (MitraFR, COAPT) will shape the future of mitral transcatheter interventions.
